Angiogenesis Induced by IL-6 and G-CSF in Rumor Tissue
Angiogenesis Induced by IL-6 and G-CSF in Rumor Tissue
批准号:
17591798
负责人:
NISHINO Hiroshi
金额:
$1.95万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Interleukin (IL)-6 and granulocyte-stimulating factor (G-CSF) are multifunctional regulator of immune response, hematopoiesis and acute phase reaction, and suppose to have the direct and/or indirect effect to the cancer cells. Recently, it has been reported that serum levels of interleukin-6 (IL-6) and expression in cancer tissues are correlated with the prognosis in various cancer patients. In this present study, we investigated that whether the proliferation and angiogenesis potential were influenced with IL-6 or G-CSF treatment in endothelial cells. Endothelial cell lines, HUV-EC-C (human, vascular endothelium, umbilical vein) and MS1 VEGF (Mouse, Pancreas vein, SV40 transformed; infected with a vector for VEGF) were used.Proliferation : MS1 VEGF was observed higher potential of proliferation than HUV-EC-C. IL-6 and G-CSF did not enhance the proliferation of HUV-EC-C and MS1 VEGF.Angiogenesis Assay : This angiogenesis assay represents a model of angiogenesis in which the induction o … More r inhibition of tube formation. Assay instructions ; 1 : Labtec II chamber slides was used, 2 : Dispense 200μL fibrinogen solution into the chamber slides, 3 : Add 13312 L per well thrombin to the chamber, 4 : Place slides at 37℃ for 60 min to polymerize, 5 : HUV-EC-C and MS1 VEGF were resuspend at a final concentration of 5 X 10^4 cells-mL in media, 6 : Add 1000 /μL HUV-EC-C and MS1 VEGF in well in chamber slides, 7 : Add 200μL per well fibrinogen in chamber slides, 8 : Add 133 μL per well thrombin in chamber slide, 8 : Place in 37℃ 5%CO_2 incubator.Angiogenesis: HUV EV-C was observed angiogenesis in angiogenesis assay, but MS1 VEGF which producted high VEGF was not observed angiogenesis in angiogenesis assay. Angiogenesis of HUV-EC-C was enhanced by bFGF 50μg/ml and/or PMA 50μg/m. Otherwise, Angiogenesis of MS1 VEGF was not enhanced by bFGF 50μg/ml and/or PMA 50μg/m.Conclusion: VEGF enhanced the proliferation of endothelial cells. MS1 VEGF which products high VEGF has high potential of proliferation, but MS1 VEGF showed poor angiogenesis (capillary formation). VEGF enhanced proliferation but not angiogenesis (capillary formation) of endothelial cells. So VEGF cause the immature vessels in tumor tissue. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rad9制御による頭頸部癌細胞死誘導の可能性の検討
研究通过 Rad9 调节诱导头颈癌细胞死亡的可能性
DOI:
--
发表时间:
2007
期刊:
頭頸部癌 33
影响因子:
--
作者:
[Yasumatsu R, Nakashima T, et al., Takeharu Kanazawa, 石川 和宏]
通讯作者:
石川 和宏
Interleukin-6 directly influences proliferation and nvasion potential of head and neck cancer cells
IL-6直接影响头颈癌细胞的增殖和侵袭能力
DOI:
--
发表时间:
2007
期刊:
Eur.Arch.Otorhinolaryngol 264
影响因子:
--
作者:
[Yasumatsu R, Nakashima T, et al., Takeharu Kanazawa]
通讯作者:
Takeharu Kanazawa
Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells
DOI:
10.1007/s00405-007-0264-6
发表时间:
2007-07-01
期刊:
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
影响因子:
2.6
作者:
[Kanazawa, Takeharu, Nishino, Hiroshi, Noda, Yutaka]
通讯作者:
Noda, Yutaka
Neural substrate underlying the formation of local receptive fields on an single antenna
-
批准号:23570087
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:NISHINO Hiroshi
-
依托单位:
Synthesis and Reaction of Butterfly-type Stable Organic Hydroperoxides
-
批准号:22550041
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:NISHINO Hiroshi
-
依托单位:
Morphological and physiological properties of neurons that code information about odor location
-
批准号:20570066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2008
-
负责人:NISHINO Hiroshi
-
依托单位:
Synthesis of Propellane-Type Heterocycles Using Tandem Cyclization
-
批准号:19550046
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2007
-
负责人:NISHINO Hiroshi
-
依托单位:
Synthesis of Jellyfish-Type Macrocyclic Molecular Flask and Efficient Reaction Using the Molecular Flask
-
批准号:15550039
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2003
-
负责人:NISHINO Hiroshi
-
依托单位:
Synthesis of a New Class of Antimalarial Cyclic Peroxide Derivatives
-
批准号:13640539
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:NISHINO Hiroshi
-
依托单位:
Biological activity of head and neck cancer cell lines with regard to IL-6 and MMP
-
批准号:12671679
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:NISHINO Hiroshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位:
养精通络方调控HIF-1α/VEGF信号通路调控“氧化应激-线粒体自噬”促进薄型子宫内膜修复的机制研究
-
批准号:2026JJ82186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾晶
-
依托单位: